The Oliver Group and Dr Mark Carrington have published a new paper in Open Biology.
Steve Oliver's group, working with Mark Carrington and colleagues elsewhere, have developed a novel tool that exploits baker's yeast to expedite the development of new drugs to fight multiple tropical diseases, including malaria, schistosomiasis, and African sleeping sickness. The unique screening method uses yeast which have been genetically engineered to express parasite and human proteins to identify chemical compounds that target disease-causing parasites but do not affect their human hosts. Read the full story on the University news website.